Pathogenesis and signaling pathways related to iodine-refractory differentiated thyroid cancer
Thyroid cancer is the most common malignant neoplasm within the endocrine system and the field of head and neck surgery. Although the majority of thyroid cancers, more than 90%, are well-differentiated thyroid carcinomas with a favourable prognosis, the escalating incidence of this disease has contr...
Main Authors: | Simeng Zhao, Yuejia Zhao, Yongfu Zhao, Guangzhi Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1320044/full |
Similar Items
-
Theranostic Options for Radioiodine-Refractory Differentiated Thyroid Carcinoma: Recent Advances, Challenges, and Road Ahead
by: Swayamjeet Satapathy, et al.
Published: (2022-07-01) -
Clinical, Pathological, and Molecular Characteristics Correlating to the Occurrence of Radioiodine Refractory Differentiated Thyroid Carcinoma: A Systematic Review and Meta-Analysis
by: Yi Luo, et al.
Published: (2020-09-01) -
Reflection Absorption Infrared Spectroscopy Characterization of SAM Formation from 8-Mercapto-<i>N</i>-(phenethyl)octanamide Thiols with Phe Ring and Amide Groups
by: Zenonas Kuodis, et al.
Published: (2020-11-01) -
Iodine avidity in papillary and poorly differentiated thyroid cancer is predicted by immunohistochemical and molecular work-up
by: Joachim N Nilsson, et al.
Published: (2023-08-01) -
Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
by: Petra Petranović Ovčariček, et al.
Published: (2023-08-01)